India Herpes Zoster Market

ID: MRFR/HC/51978-HCR

200 Pages

Rahul Gotadki

September 2025

India Herpes Zoster Market Research Report By Diagnosis (Laboratory Testing, Immunofluorescent Microscopy, Real-Time Polymerase Chain Reaction (PCR), Serological Testing, Others), By Treatment and Prevention (Antiviral Medications, Narcotic Medications, Anti-Inflammatory Medications, Antihistamines, Anticonvulsants, Capsaicin, Numbing Creams, Gels, or Patches, Vaccines, Others), By Route of Administration (Oral, Topical, Others) and By End User (Hospitals &amp; Clinics, Diagnostic Centers, Research &amp; Academic Institutes, Home Car...

India Herpes Zoster Market Research Report-Forecast to 2035 Infographic

Single User

$ 4,950.0

Multiple License

$ 5,950.0

Enterprise User

$ 7,250.0

Summary Table of Contents Segmentation Infographic

1. Market Overview

2. Market Trends

3. Market Segment Insights

4. Key Players and Competitive Insights

5. Industry Developments

6. Market Segmentation

7. Report Scope

8. Market Highlights

9. FAQs

Customize Report

Certified Researchers

India Herpes Zoster Market Summary

The India Herpes Zoster market is projected to grow from 250 USD Million in 2024 to 750 USD Million by 2035.

Key Market Trends & Highlights

India Herpes Zoster Key Trends and Highlights

The market is expected to experience a compound annual growth rate (CAGR) of 10.5% from 2025 to 2035.
By 2035, the market valuation is anticipated to reach 750 USD Million, indicating robust growth.
In 2024, the market is valued at 250 USD Million, reflecting the current demand for Herpes Zoster treatments in India.
Growing adoption of advanced treatment options due to increasing awareness of Herpes Zoster is a major market driver.

India Herpes Zoster Market

CAGR

10.5%

Market Size & Forecast

2024 Market Size	250 (USD Million)
2035 Market Size	750 (USD Million)
CAGR (2025 - 2035)	10.5%

Major Players

Reliance Industries Limited (IN), Tata Consultancy Services (IN), HDFC Bank Limited (IN), Infosys Limited (IN), ICICI Bank Limited (IN), Hindustan Unilever Limited (IN), State Bank of India (IN), Bharti Airtel Limited (IN), Wipro Limited (IN), Asian Paints Limited (IN)

India Herpes Zoster Market Trends

In India, the Herpes Zoster market is experiencing several important trends driven by demographic and healthcare factors. One key market driver is the rising aging population, as a significant portion of the Indian populace is over the age of 50, thereby increasing the susceptibility to Herpes Zoster infections. This demographic shift highlights the need for effective vaccination strategies and treatment options. Furthermore, the growing awareness regarding the disease, spurred by educational campaigns from government health bodies and healthcare providers, has led to an increased demand for vaccines and medical assistance.

Opportunities in the India Herpes Zoster market specifically revolve around expanding vaccination programs.The Indian government has emphasized the importance of vaccinations in its public health policies, which can be leveraged to reach underserved populations. This presents a chance for pharmaceutical companies to introduce new and improved vaccines and treatment protocols while collaborating with local health authorities. The introduction of these health measures can further boost market growth. Trends in recent times also reflect a shift towards digital health solutions, with telemedicine gaining traction in India.

Market Segment Insights

India Herpes Zoster Market Segment Insights

Herpes Zoster Market Diagnosis Insights

The India Herpes Zoster Market under the Diagnosis segment plays a pivotal role in ensuring accurate identification and treatment of this viral infection. Given the increasing prevalence of herpes zoster in India, there is heightened attention towards diagnostic methodologies that can efficiently detect the varicella-zoster virus. Diagnosis methods, including Laboratory Testing, are fundamental as they provide essential data for confirming the presence of the virus in affected individuals, which can assist healthcare providers in making informed decisions regarding treatment plans.

Immunofluorescent Microscopy is another significant diagnostic tool that allows for the visualization of viral particles, playing a crucial role in rapid diagnosis, which is vital for effective patient management. Furthermore, Real-Time Polymerase Chain Reaction (PCR) is gaining traction for its high sensitivity and specificity, marking an advancement in detection techniques. This technology not only enhances diagnostic accuracy but also aids in the early identification of the virus, thereby decreasing potential complications associated with delayed treatment.

The Serological Testing approach is prominent as it measures the body's immune response to the virus, providing additional insights into the infection status of the patient. Each of these diagnostic methods presents unique advantages, fostering a comprehensive understanding of the herpes zoster infection landscape. The rising awareness of herpes zoster, coupled with the growing adoption of advanced diagnostic technologies, presents significant growth opportunities for the India Herpes Zoster Market. The Indian healthcare system is also witnessing a need for increased accessibility to these diagnostic tools, which is imperative in a country where the burden of viral infections is considerable.

Despite the challenges posed by limited healthcare resources in certain regions, the trends indicate a steady investment in healthcare infrastructure aimed at improving diagnostic capabilities. As a result, the future of the Diagnosis segment within the India Herpes Zoster Market seems poised for expansion, reflecting both the growing demand for accurate diagnostic methods and the ongoing development in medical technologies designed to combat viral infections. Enhanced training and education of healthcare practitioners on these diagnosis methodologies can lead to more prompt and accurate identification of herpes zoster, thus supporting the overall health objectives within the Indian populace.

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Herpes Zoster Market Treatment and Prevention Insights

The Treatment and Prevention segment of the India Herpes Zoster Market has gained prominence due to increasing awareness about the disease and the associated healthcare initiatives. Key areas within this segment are Antiviral Medications, which are essential for reducing the severity and duration of the outbreak, thereby playing a crucial role in patient care. Narcotic Medications provide much-needed pain relief, especially for patients experiencing postherpetic neuralgia, making them significant in therapeutic approaches.

Anti-Inflammatory Medications help alleviate inflammation related to herpes zoster rashes, while Antihistamines serve to minimize itching and discomfort, enhancing overall patient well-being.Anticonvulsants are increasingly recognized for their effectiveness in managing neuropathic pain associated with shingles, making their utilization quite valuable. Capsaicin, Numbing Creams, Gels, or Patches also contribute to topical treatments, offering relief and complementing systemic therapies. Additionally, Vaccines are vital in preventing herpes zoster, presenting a proactive approach in the healthcare landscape of India.

This comprehensive range of treatment options highlights the diversity of the India Herpes Zoster Market, catering to the varied needs of patients while reflecting changing dynamics in healthcare strategies and provider offerings.The growing adoption of these treatments speaks to broader health trends, as advancements and innovations continue to shape treatment paradigms in India.

Herpes Zoster Market Route of Administration Insights

The India Herpes Zoster Market demonstrates a varied Route of Administration segmentation, notably encompassing Oral, Topical, and Others, which plays a crucial role in treatment choices and patient compliance. Oral medications are often preferred due to their convenience and ease of administration, significantly catering to the larger base of patients seeking effective management of herpes zoster symptoms.

Topical treatments, on the other hand, are essential for localized relief, providing targeted action to alleviate pain and discomfort, which appeals to patients looking for immediate symptom relief without systemic side effects.Other administration routes, while less common, may include intramuscular or intravenous options, serving specific patient needs based on severity or complications from the condition. The growth of the India Herpes Zoster Market is driven by increasing awareness, improved healthcare access, and the aging population, which contributes to a higher incidence of the disease.

Furthermore, advancements in formulation technologies and efficacy enhancements within these routes are expected to bolster market growth. As the healthcare landscape in India evolves, these administration routes will significantly influence treatment paradigms, highlighting the importance of adaptable therapeutic approaches in addressing herpes zoster effectively.

Herpes Zoster Market End User Insights

The India Herpes Zoster Market is significantly shaped by its End User segmentation, comprising Hospitals and Clinics, Diagnostic Centers, Research and Academic Institutes, Home Care Settings, and Others, which collectively cater to the medical needs of patients. Hospitals and Clinics are crucial as they provide immediate and comprehensive care options for individuals diagnosed with herpes zoster, promoting timely treatment and reducing complications.

Diagnostic Centers play a vital role in facilitating accurate diagnosis, thereby streamlining patient care pathways and contributing to improved outcomes.Meanwhile, Research and Academic Institutes are key contributors to ongoing studies and advancements in treatment options, essential for addressing the evolving challenges posed by herpes zoster. Home Care Settings are increasingly important for post-treatment recovery, offering personalized care that accommodates the comfort of patients in their homes. This diversification in end-user settings highlights the market's adaptive nature, reflecting a growing inclination towards outpatient and home-based healthcare solutions in India.

The focus on enhancing patient care through various channels is influenced by population health trends, thereby adding a critical dimension to market growth opportunities within the India Herpes Zoster Market.

Get more detailed insights about India Herpes Zoster Market Research Report-Forecast to 2035

Request Free Sample

Key Players and Competitive Insights

The India Herpes Zoster Market has witnessed significant competitive dynamics in recent years, driven by the increasing prevalence of the disease in the population and a growing awareness about its potential complications. In this market, numerous players have emerged, each bringing diverse strategies, product offerings, and innovations that contribute to the competitive landscape. The need for effective treatment and preventive measures against herpes zoster, commonly known as shingles, has led to the introduction of vaccines and antiviral therapies by various companies.

The market is characterized by both multinational corporations and local enterprises striving to increase their market share, providing a rich environment for competitive analysis.GlaxoSmithKline holds a notable position within the India Herpes Zoster Market, leveraging its extensive experience and strong reputation in the pharmaceutical sector. The company has established a firm foothold through its innovative vaccine offerings, which are crucial in preventing the onset of shingles. Its robust research and development capabilities enable GlaxoSmithKline to stay at the forefront of medical advancements while addressing the healthcare needs specific to Indian demographics.

The company's well-distributed supply chain enhances its accessibility across the country, ensuring that healthcare providers and patients can easily access its products. Furthermore, strong partnerships with healthcare institutions augment GlaxoSmithKline's presence and elevate its market strength in combating herpes zoster.Biocon is another significant player in the India Herpes Zoster Market, focusing on a variety of healthcare solutions. The company's product portfolio includes biosimilars that are critical in the treatment protocols of herpes zoster, along with other related viral infections.

Biocon has been successful in fostering a strong market presence through strategic collaborations and a commitment to the affordability and accessibility of its products. The company's strengths lie in its innovative research capabilities, which have led to addressing unmet medical needs in the region. Biocon's mergers and acquisitions have further solidified its role within the market, enhancing its capabilities in drug development and commercialization initiatives that cater specifically to the Indian healthcare landscape. With a focus on making healthcare solutions more accessible, Biocon continues to play a vital role in the fight against herpes zoster in India.

Key Companies in the India Herpes Zoster Market market include

Industry Developments

The India Herpes Zoster Market has seen significant developments recently, particularly with a focus on vaccination and treatment options. Notably, GlaxoSmithKline has been actively involved in promoting its shingles vaccine, which has garnered attention due to increased awareness about the disease. In May 2023, Dr. Reddy's Laboratories announced the launch of its generic version of a popular antiviral used in herpes zoster treatment, thereby expanding treatment options for patients and enhancing its market standing.

In terms of market growth, the sector has witnessed a steady increase in valuation, attributed to rising incidences of shingles among the aging population and greater healthcare investment from the Indian government, emphasizing preventive healthcare initiatives. Moreover, in August 2022, Hetero Labs expanded its manufacturing capabilities for antiviral medications, which contributed positively to the availability of critical therapies. There have been no recent mergers or acquisitions reported among key players like Pfizer, Biocon, or Lupin Pharmaceuticals in this specific market, indicating a stable competitive landscape.

Overall, the India Herpes Zoster Market is evolving with advancements in treatment and preventive strategies aligned with national health priorities.

Market Segmentation

Outlook

Hospitals & Clinics
Diagnostic Centers
Research & Academic Institutes
Home Care Settings
Others

Report Scope

Report Attribute/Metric Source:	Details
MARKET SIZE 2023	11.88(USD Million)
MARKET SIZE 2024	15.0(USD Million)
MARKET SIZE 2035	28.5(USD Million)
COMPOUND ANNUAL GROWTH RATE (CAGR)	6.009% (2025 - 2035)
REPORT COVERAGE	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR	2024
MARKET FORECAST PERIOD	2025 - 2035
HISTORICAL DATA	2019 - 2024
MARKET FORECAST UNITS	USD Million
KEY COMPANIES PROFILED	GlaxoSmithKline, Biocon, Bharat Biotech, Pfizer, Lupin Pharmaceuticals, Gennova Biopharmaceuticals, Dr. Reddy's Laboratories, Hetero Labs, Zydus Cadila, Indian Immunologicals, AstraZeneca, Merck & Co, Sanofi, Novartis, Mylan
SEGMENTS COVERED	Diagnosis, Treatment and Prevention, Route of Administration, End User
KEY MARKET OPPORTUNITIES	Increasing vaccination awareness, Rising elderly population, Expanding healthcare infrastructure, Growing telemedicine adoption, Enhanced antiviral drug development
KEY MARKET DYNAMICS	increasing prevalence of shingles, rising geriatric population, awareness about vaccination, advancements in antiviral therapies, government health initiatives
COUNTRIES COVERED	India

FAQs

What is the expected market size of the India Herpes Zoster Market in 2024?

The India Herpes Zoster Market is expected to be valued at 15.0 million USD in 2024.

What is the projected market size for the India Herpes Zoster Market by 2035?

By 2035, the India Herpes Zoster Market is projected to reach a value of 28.5 million USD.

What is the expected CAGR for the India Herpes Zoster Market from 2025 to 2035?

The expected CAGR for the India Herpes Zoster Market from 2025 to 2035 is 6.009 percent.

Which diagnostic segment has the highest market value in 2024?

The Laboratory Testing segment has the highest market value, estimated at 4.5 million USD in 2024.

What is the market size of the Real-Time Polymerase Chain Reaction (PCR) segment in 2024?

The Real-Time Polymerase Chain Reaction (PCR) segment is valued at 2.5 million USD in 2024.

Who are the key players in the India Herpes Zoster Market?

Major players in the market include GlaxoSmithKline, Biocon, Pfizer, and Dr. Reddy's Laboratories among others.

How much is the Serological Testing segment projected to be valued at by 2035?

The Serological Testing segment is projected to be valued at 3.8 million USD by 2035.

What is the market value for the Immunofluorescent Microscopy segment in 2035?

The Immunofluorescent Microscopy segment is expected to reach a market value of 5.7 million USD by 2035.

What opportunities exist for growth in the India Herpes Zoster Market?

Emerging trends such as increased awareness and advancements in diagnostics present growth opportunities.

What challenges could impact the growth of the India Herpes Zoster Market?

Challenges may include regulatory hurdles and competition from alternative treatment options.

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Customer Stories

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Victoria Milne Founder

Case Study

Chemicals and Materials

Global Magnesium Sulfate Market – Forecast till 2027